|
|
Other links at Articles > Allergy and Clinical Immunology |
| 4. |
FDA Safety Changes: Levaquin, NovoLog, Zevalin
|
|
|
The FDA has approved revisions to the safety labeling for levofloxacin (Levaquin), insulin aspart [rDNA origin] injection (NovoLog), and ibritumomab tiuxetan injection (Zevalin). Medscape Medical News
|
|
|